Research Goals

Julia Feichtinger's research focus lies on the large-scale analyses of transcriptomics and (epi)genomics data, in particular relating to long non-coding RNAs.

Exploiting the large amount of available sequencing data enables us to construct a comprehensive picture of gene expression patterns across tissues, diseases and cell types and, therefore, will help us to better understand the underlying mechanisms of gene expression regulation and its dysregulation in diseases.

Advances in this field will greatly promote molecular biology and clinical/biomedical research. Furthermore, we support biologists with biostatistics and bioinformatics analyses.

To top

Current Projects

  • FWF Project T 923-B26 - Antisense and Allele-specific Transcription in Human Cancer
    January 2018 - June 2021

    We are investigating two widespread transcriptional phenomena, antisense and allele-specific transcription, in a large-scale study. Antisense transcripts are at least partially complementary to a corresponding (mainly protein-coding) sense transcript and can have diverse functional roles in gene regulation (e.g., modifying epigenetic marks). This genomic arrangement also clearly suggests that antisense transcripts are mainly involved in allele-specific gene regulation/silencing. We aim to construct a comprehensive picture of these processes in a large panel of cancer samples and healthy controls by making use of the current wealth of transcriptomics and (epi)genomics data provided in the constantly growing public repositories. This will not only lead to new insights into gene regulation and provide new diagnostic/prognostic marker and drug target candidates for clinical applications but could also change the paradigm on how we conduct gene expression analyses in the future.

To top

Current Theses

I am currently looking for master students! Have a look if you are interested - more details here.

To top

Completed Theses

MSc Theses

  • Raphael Hablesreiter: Establishment of an Analysis Pipeline for Public Cancer Gene Expression Sequencing Datasets


To top

Selected Publications

B Burja, T Kuret, S Sodin-Semrl, K Lakota, Ž Rotar, R Ješe, K Mrak-Poljšak, P Žigon, G G Thallinger, J Feichtinger, S Čučnik, M Tomšič, S Praprotnik and A Hočevar A concise review of significantly modified serological biomarkers in giant cell arteritis, as detected by different methods Show publication in PURE
Julia J Unterluggauer, Katharina Prochazka, Peter V Tomazic, Heinrich J Huber, Rita Seeboeck, Karoline Fechter, Elisabeth Steinbauer, Verena Gruber, Julia Feichtinger, Martin Pichler, Marc A Weniger, Ralf Küppers, Heinz Sill, Rudolf Schicho, Peter Neumeister, Christine Beham-Schmid, Alexander J A Deutsch and Johannes Haybaeck Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome Show publication in PURE
Karoline Fechter, Julia Feichtinger, Katharina Prochazka, Julia Judith Unterluggauer, Katrin Pansy, Elisabeth Steinbauer, Martin Pichler, Johannes Haybaeck, Andreas Prokesch, Hildegard T Greinix, Christine Beham-Schmid, Peter Neumeister, Gerhard G Thallinger and Alexander J A Deutsch Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival Show publication in PURE
Bhupesh K Prusty, Nitish Gulve, Sheila Govind, Gerhard R F Krueger, Julia Feichtinger, Lee Larcombe, Richard Aspinall, Dharam V Ablashi and Carla T Toro Active HHV-6 Infection of Cerebellar Purkinje Cells in Mood Disorders Show publication in PURE
Katja Lakota, Julia Feichtinger, Blaž Burja, Tadeja Kuret, Polona Žigon, Žiga Rotar, Rok Ješe, Snezna Sodin-Semrl, Saša Čučnik, Gerhard G Thallinger, Matija Tomšič and Alojzija Hočevar Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients 219 Show publication in PURE
Julia Feichtinger, Christoph Fischer, Inmaculada Hernandez, Heena Dhiman, Nicole Borth and Gerhard Thallinger Comprehensive Analysis of Genomic Data for 16 CHO Cell Lines to Investigate the (In)stability of the CHO Genome Show publication in PURE
Alexander J A Deutsch, Beate Rinner, Martin Pichler, Katharina Prochazka, Katrin Pansy, Marco Bischof, Karoline Fechter, Stefan Hatzl, Julia Feichtinger, Kerstin Wenzl, Marie-Therese Frisch, Verena Stiegelbauer, Andreas Prokesch, Anne Krogsdam, Heinz Sill, Gerhard G Thallinger, Hildegard T Greinix, Chenguang Wang, Christine Beham-Schmid and Peter Neumeister NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes Show publication in PURE
Blaž Burja, Julia Feichtinger, Katja Lakota, Gerhard G Thallinger, Snezna Sodin-Semrl, Tadeja Kuret, Žiga Rotar, Rok Ješe, Polona Žigon, Saša Čučnik, Polonca Mali, Sonja Praprotnik, Matija Tomšič and Alojzija Hočevar Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients Show publication in PURE
Tadeja Kuret, Blaž Burja, Julia Feichtinger, Gerhard G Thallinger, Mojca Frank-Bertoncelj, Katja Lakota, Polona Žigon, Snezna Sodin-Semrl, Saša Čučnik, Matija Tomšič and Alojzija Hočevar Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies Show publication in PURE

To top

Team Leader

Julia Feichtinger
Dipl.-Ing. MSc PhD

Julia Feichtinger